AEE alleviates ox-LDL-induced lipid accumulation and inflammation in macrophages
Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved..
Atherosclerosis is a chronic immune inflammatory disease. Aspirin eugenol ester (AEE) is a novel safe and non-toxic compound with many pharmacological effects such as anti-inflammatory, anti-hyperlipidemic and anti-thrombotic action. In order to investigate the effect of AEE on the inhibition of aortic lipid plaque formation and macrophage-derived foam cell formation induced by oxidized low density lipoprotein (ox-LDL), in vivo atherosclerosis model by feeding ApoE-/- mice with a high-fat diet and foam cells formation in vitro model by ox-LDL-induced RAW264.7 macrophages were established. It was found that AEE decreased the levels of TC and LDL-C in serum, and the plaque formation area and lipid accumulation in the aortic intima of ApoE-/- mice. In vitro studies showed that AEE could prevent the uptake of ox-LDL and reduce the contents of TC and FC in cells. AEE enhanced the cholesterol efflux by increasing the expression of ABCA1, ABCG1 and PPARγ, which effectively alleviated excess cholesterol accumulated in the cells. Meanwhile, AEE also reduced the secretion and expression of inflammatory factors in the cells. In addition, AEE could reverse the action of PPARγ inhibitor T0070907 and/or ox-LDL. Therefore, AEE may become an effective candidate drug for the prevention of atherosclerosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:167 |
|---|---|
| Enthalten in: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 167(2023) vom: 01. Nov., Seite 115486 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Ya-Xian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aspirin eugenol ester (AEE) |
|---|
| Anmerkungen: |
Date Revised 17.10.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.biopha.2023.115486 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362059276 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362059276 | ||
| 003 | DE-627 | ||
| 005 | 20231226090439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.biopha.2023.115486 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM362059276 | ||
| 035 | |a (NLM)37708693 | ||
| 035 | |a (PII)S0753-3322(23)01284-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Ya-Xian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a AEE alleviates ox-LDL-induced lipid accumulation and inflammation in macrophages |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved. | ||
| 520 | |a Atherosclerosis is a chronic immune inflammatory disease. Aspirin eugenol ester (AEE) is a novel safe and non-toxic compound with many pharmacological effects such as anti-inflammatory, anti-hyperlipidemic and anti-thrombotic action. In order to investigate the effect of AEE on the inhibition of aortic lipid plaque formation and macrophage-derived foam cell formation induced by oxidized low density lipoprotein (ox-LDL), in vivo atherosclerosis model by feeding ApoE-/- mice with a high-fat diet and foam cells formation in vitro model by ox-LDL-induced RAW264.7 macrophages were established. It was found that AEE decreased the levels of TC and LDL-C in serum, and the plaque formation area and lipid accumulation in the aortic intima of ApoE-/- mice. In vitro studies showed that AEE could prevent the uptake of ox-LDL and reduce the contents of TC and FC in cells. AEE enhanced the cholesterol efflux by increasing the expression of ABCA1, ABCG1 and PPARγ, which effectively alleviated excess cholesterol accumulated in the cells. Meanwhile, AEE also reduced the secretion and expression of inflammatory factors in the cells. In addition, AEE could reverse the action of PPARγ inhibitor T0070907 and/or ox-LDL. Therefore, AEE may become an effective candidate drug for the prevention of atherosclerosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Aspirin eugenol ester (AEE) | |
| 650 | 4 | |a Atherosclerosis | |
| 650 | 4 | |a Foam cell | |
| 650 | 4 | |a NF-κB | |
| 650 | 4 | |a PPARγ | |
| 700 | 1 | |a Liu, Xi-Wang |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Ya-Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Shi-Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Bai, Li-Xia |e verfasserin |4 aut | |
| 700 | 1 | |a Ge, Wen-Bo |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Xiao |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Cun |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Jian-Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Qin, Zhe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |d 1984 |g 167(2023) vom: 01. Nov., Seite 115486 |w (DE-627)NLM012645591 |x 1950-6007 |7 nnns |
| 773 | 1 | 8 | |g volume:167 |g year:2023 |g day:01 |g month:11 |g pages:115486 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biopha.2023.115486 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 167 |j 2023 |b 01 |c 11 |h 115486 | ||